Consent to the Distribution of a New Medicine Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto: Schedule Name and Strength Form Name and Address of Manufacturer Proprietary Name(if any) Human albumin 200 g/L in 10 mL, 100 mL Solution, infusion, bottle CSL Limited, Broadmeadows, Victoria, Australia Albumex 20 Human albumin 40 g/L in 50 mL, 500 mL Solution, infusion, bottle CSL Limited, Broadmeadows, Victoria, Australia Albumex 4 Iothalamate sodium 700 mg/mL, phenol 120 mg/mL in 10 mL Injection, ampoule McGaw Biomed Limited, Point Chevalier, Auckland, New Zealand Phenol 12% in Sodium Iothalamate 70% Urea-[su'13']C 100 mg Tablet Penn Pharmaceuticals Limited, Tredegar, Gwent, United Kingdom Urea-[su'13']C Alfuzosin hydrochloride 2.5 mg Tablet, film coated Synthelabo Group, Tours, France Xatral Alfuzosin hydrochloride 5 mg Tablet, sustained release, film coated Synthelabo Group, Tours, France Xatral SR Dated this 10th day of October 1997. G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on 20 February 1997.